Lars Rombo

Countries

This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.

Institutions

• GlaxoSmithKline (Belgium)22.6%
• Centers for Disease Control and Prevention9.6%
• National Institutes of Health8.5%
• GlaxoSmithKline (United States)6.9%
• University of Oxford6.1%
• National Institute of Allergy and Infectious Diseases6%
• Other40.4%

Fields

• Medicine79.2%
• Biochemistry, Genetics and Molecular Biology10.4%
• Immunology and Microbiology6.1%
• Social Sciences1.4%
• Agricultural and Biological Sciences0.9%
• Environmental Science0.4%
• Other1.6%

Topics

• Herpesvirus Infections and Treatments21.5%
• Malaria Research and Control13.9%
• Cytomegalovirus and herpesvirus research8.3%
• Mosquito-borne diseases and control7.7%
• SARS-CoV-2 and COVID-19 Research7.4%
• Facial Nerve Paralysis Treatment and Research5.7%
• Other35.5%